QQQ   419.63 (-0.89%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.75 (-0.19%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.99 (-1.28%)
CGC   7.72 (-1.40%)
DIS   111.81 (-0.55%)
AMC   3.12 (+6.85%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.18 (+1.40%)
QQQ   419.63 (-0.89%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.75 (-0.19%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.99 (-1.28%)
CGC   7.72 (-1.40%)
DIS   111.81 (-0.55%)
AMC   3.12 (+6.85%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.18 (+1.40%)
QQQ   419.63 (-0.89%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.75 (-0.19%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.99 (-1.28%)
CGC   7.72 (-1.40%)
DIS   111.81 (-0.55%)
AMC   3.12 (+6.85%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.18 (+1.40%)
QQQ   419.63 (-0.89%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.75 (-0.19%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.99 (-1.28%)
CGC   7.72 (-1.40%)
DIS   111.81 (-0.55%)
AMC   3.12 (+6.85%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.18 (+1.40%)
Free Trial

Marker Therapeutics (MRKR) SEC Filings & 10K Form

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)
Free MRKR Stock Alerts
$4.05
-0.05 (-1.22%)
(As of 10:37 AM ET)
Compare
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability

Recent Marker Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
04/08/2024
6:09 AM		Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2024
7:02 AM		Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2024
6:58 AM		Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
7:30 AM		Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2023
6:35 AM		Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2023
3:37 PM		Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2023
6:10 AM		Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2023
6:22 AM		Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2023
6:09 AM		Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2023
3:05 PM		Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2023
6:14 AM		Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2023
6:09 AM		Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2023
8:35 PM		Eansor Norman David (Reporting)
Marker Therapeutics, Inc. (Issuer)
Marker Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
8:32 PM		ELMS STEVE (Reporting)
Marker Therapeutics, Inc. (Issuer)
Marker Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
8:33 PM		Marker Therapeutics, Inc. (Issuer)
Marker Therapeutics (Issuer)
Wilson John Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
8:34 PM		Knobil Katharine (Reporting)
Marker Therapeutics, Inc. (Issuer)
Marker Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
5:44 AM		Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2023
5:10 PM		Marker Therapeutics, Inc. (Issuer)
Marker Therapeutics (Issuer)
Vera Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2023
6:45 AM		Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2023
6:36 AM		Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2023
3:09 PM		Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form ARS
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:MRKR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Urgent alert: open this for a huge profit potential
Timothy Sykes